EUVIMEDEUVIMED entdecken
Crossref

ZnS/Ag 2 S@PDA Core–Shell Heterojunctions for NIR‑Driven Photothermal Therapy of Cervical Cancer

Guoyu Wu, Yunqing Zhang, Xiaoyu Zhang, Meng Zhou, Lihua Wang, Jingjing Liu, Sirun Duo, Weimin Gao, Shuwang Duo

ChemistrySelect · 2026-11 · 11 (44)

DOI: 10.1002/slct.75189 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemistrySelect, online erschienen am 17.11.2026. Verfasst von Guoyu Wu und 8 weiteren Autor:innen. Die Arbeit nennt 29 Literaturangaben. Gefördert von: Natural Science Foundation of Jiangxi Province.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Photothermal therapy (PTT) offers spatially controlled and minimally invasive tumor ablation, but its efficacy depends strongly on the NIR responsiveness of photothermal agents. Here, a ZnS/Ag 2 S@PDA core–shell heterostructure was developed by combining semiconductor heterointerface engineering with PDA‐mediated surface modification. Ag 2 S incorporation decreased the apparent optical transition energy from 3.83 to 2.64 eV and broadened the optical response, while the PDA shell provided additional broadband NIR absorption. The enhanced 808 nm photothermal behavior was not simply attributed to bandgap narrowing, but rather to the combined contributions of Ag 2 S‐related sub‐bandgap/interfacial absorption, non‐radiative relaxation, and PDA‐assisted NIR absorption. ZnS/Ag 2 S@PDA exhibited strong concentration‐dependent heating under 808 nm irradiation. In vitro, HeLa cell viability decreased to below 25% at 200 µg/mL under laser irradiation, whereas viability remained above 75% without irradiation. In a preliminary HeLa xenograft model, ZnS/Ag 2 S@PDA combined with laser irradiation markedly suppressed tumor growth, with relative tumor volume decreasing to below 0.5‐fold of the initial value by Day 14. These results demonstrate the potential of ZnS/Ag 2 S@PDA as an NIR‐responsive photothermal nanoplatform and clarify the relationship between heterostructure design, optical response, and therapeutic performance.

Förderung

  • Natural Science Foundation of Jiangxi Province

Zitieren

APA

Wu, G., Zhang, Y., Zhang, X., Zhou, M., Wang, L., Liu, J., Duo, S., Gao, W., & Duo, S. (2026). ZnS/Ag 2 S@PDA Core–Shell Heterojunctions for NIR‑Driven Photothermal Therapy of Cervical Cancer. ChemistrySelect, 11(44). https://doi.org/10.1002/slct.75189

Vancouver

Wu G, Zhang Y, Zhang X, Zhou M, Wang L, Liu J, et al. ZnS/Ag 2 S@PDA Core–Shell Heterojunctions for NIR‑Driven Photothermal Therapy of Cervical Cancer. ChemistrySelect. 2026;11(44). doi:10.1002/slct.75189

BibTeX
@article{Wu2026,
  author = {Wu, Guoyu and Zhang, Yunqing and Zhang, Xiaoyu and Zhou, Meng and Wang, Lihua and Liu, Jingjing and Duo, Sirun and Gao, Weimin and Duo, Shuwang},
  title = {ZnS/Ag 2 S@PDA Core–Shell Heterojunctions for NIR‑Driven Photothermal Therapy of Cervical Cancer},
  journal = {ChemistrySelect},
  year = {2026},
  volume = {11},
  number = {44},
  doi = {10.1002/slct.75189}
}
Kostenlos starten →